CRPOF

$0.17-$0.03 (-13.04%)prev close

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Price (6 mo)

Loading chart…

Change$-0.31

Valuation

Trading at 0.8× sales vs its 2.2× historical median P/S.

Fair value ≈ $0.45 · price $0.17 today

Undervalued · 62% below

Loading valuation…

Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.

Valuation

Financials

Loading chart…

Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.

	2016	2017	2018	2019	2020	2021	2022	2023
Revenue	$13.7M	$12.9M	$11.6M	$12.9M	$15.1M	$17.2M	$18.8M	$9.6M
Cost of revenue	$4.3M	$5.7M	$5.5M	$7.4M	$7.5M	$7.5M	$7.8M	$6.1M
Gross profit	$9.4M	$7.3M	$6.1M	$5.4M	$7.6M	$9.7M	$11.0M	$3.6M
Gross margin	68.4%	56.3%	52.9%	42.3%	50.4%	56.3%	58.5%	37.0%
R&D	$919.1K	$1.6M	$2.7M	$2.4M	$1.9M	$3.8M	$1.8M	$2.8M
Operating income	$6.0M	$2.7M	$128.1K	−$586.7K	$2.1M	$2.4M	$5.3M	−$6.3M
EBITDA	$6.4M	$110.9K	$371.5K	$1.1M	$4.0M	$4.7M	$7.5M	−$3.8M
Net income	$3.6M	−$958.3K	−$315.5K	−$1.1M	$1.9M	$3.4M	$4.4M	−$4.7M
Net margin	26.5%	-7.4%	-2.7%	-8.8%	12.3%	19.6%	23.3%	-48.9%
EPS (diluted)	0.05	-0.01	-0.00	-0.01	0.02	0.04	0.06	-0.06

Annual figures · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
CRPOFCeapro Inc.	$0.17	-13.04%	$13M	—
ABDXFAbingdon Health Plc	$0.14	+0.00%	$26M	—
AMHVAmerican Hemp Ventures, Inc.	$0.98	+0.00%	$16M	—
EIGRQEiger BioPharmaceuticals, Inc.	$8.50	+6.25%	$13M	—
LVCLYLiving Cell Technologies Limited	$0.03	+24.39%

Held by traders on TradeandTell

No one on the platform currently holds CRPOF.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in CRPOF as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded CRPOF yet.

$CRPOF chatter on StockTwits

Asafo Yerodin@fatDNAMar 13
$CRPOF alot more dissidents of deal than $AEZS when deal close?
View on StockTwits ↗
bhusga@bhusgaMar 12
$CRPOF merger is approved by security holders.
View on StockTwits ↗
Asafo Yerodin@fatDNAJan 4
$CRPOF $AEZS when deal close?
View on StockTwits ↗
Daniel Ward, CFA@Daniel_WardDec 15
$AEZS $CRPOF Merger News Commentary -I’m still digesting. -The stock trading <2% of shares and closing flat shows the market’s low enthusiasm. -The board overlap between AEZS and CRPOF creates questions. -If I vote no, I am fairly confident shareholders can reject merger.
View on StockTwits ↗
StockTitan@Stock_TitanNov 29
$CRPOF Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights Article Available on StockTitan Website.
View on StockTwits ↗
StockTitan@Stock_TitanNov 27
$CRPOF Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases Article Available on StockTitan Website.
View on StockTwits ↗
MarketBeat Earnings@EarningsInsiderNov 11
Ceapro Sees Short Interest Decrease from 5,300 shares to 1,100 shares. $CRPOF https://www.marketbeat.com/stocks/OTCMKTS/CRPOF/short-interes
View on StockTwits ↗
StockTitan@Stock_TitanNov 7
$CRPOF Ceapro Inc. Enters into Technical Collaboration with NATEX Prozesstechnologie GmbH and Provides Update on the Scale-Up Project for its Patented Pressurized Gas eXpanded (PGX) Technology https://www.stocktitan.net/news/CRPOF/ceapro-inc-enters-into-technical-collaboration-with-natex-3bcll1mml5k2.html
View on StockTwits ↗
StockTitan@Stock_TitanAug 29
$CRPOF Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results and Provides Corporate Update https://www.stocktitan.net/news/CRPOF/ceapro-inc-reports-2023-second-quarter-and-six-month-financial-40s23b0u6mmc.html
View on StockTwits ↗
StockTitan@Stock_TitanAug 25
$CRPOF Ceapro Extends Exclusive International Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise https://www.stocktitan.net/news/CRPOF/ceapro-extends-exclusive-international-supply-and-distribution-as33jsxkg65m.html
View on StockTwits ↗
StockTitan@Stock_TitanJul 18
$CRPOF Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation https://www.stocktitan.net/news/CRPOF/ceapro-announces-next-phase-of-research-collaboration-with-the-hbfz7t4vlldw.html
View on StockTwits ↗
StockTitan@Stock_TitanJul 5
$CRPOF Ceapro to Participate in the Virtual Investor Summer Spotlight Series https://www.stocktitan.net/news/CRPOF/ceapro-to-participate-in-the-virtual-investor-summer-spotlight-u8forarq3nr1.html
View on StockTwits ↗
MarketBeat Earnings@EarningsInsiderJun 12
Ceapro Sees Short Interest Increase from 4,600 shares to 18,500 shares. $CRPOF https://www.marketbeat.com/stocks/OTCMKTS/CRPOF/short-intere
View on StockTwits ↗
FlashAlert_me@flaJun 7
$CRPOF [15s. delayed]: Issued Press Release on June 07, 09:05:00: Ceapro Announces Results of 2023 Shareholders’ Meeting https://s.flashalert.me/hKQwYO
View on StockTwits ↗
StockTitan@Stock_TitanJun 7
$CRPOF Ceapro Announces Results of 2023 Shareholders’ Meeting https://www.stocktitan.net/news/CRPOF/ceapro-announces-results-of-2023-shareholders-dsigtr36uhn6.html
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.